Astrazeneca Pharma Polandsp. z o.o.
Other research and experimental development on natural sciences and engineering
Overview
Astrazeneca Pharma Poland is a biopharmaceutical company that develops and manufactures medicines for major challenges in modern medicine. Its therapeutic areas include oncology, cardiovascular and metabolic diseases, respiratory diseases, autoimmune conditions, neurological diseases, infectious diseases and vaccines.
Financials
Revenue history (in m)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2003-10-01. Active
43 1030 1508 0000 0005 0287 6007- 96 1030 1508 0000 0005 0287 6023
- 21 1030 1508 0000 0005 0287 6015
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Real estate
| Type | Amount |
|---|---|
Buildings and premises | PLN 547.9KPLN 547,861 |
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Mar 31, 2025 | Aid for research and development projects: experimental development | $1.7M$1,687,095 | PIERWSZY MAZOWIECKI URZĄD SKARBOWY W WARSZAWIE |
Tenders
4 tenders recorded as contractor, with a total value of $7,497,699.
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Sep 3, 2026 | Przetarg uzupełniający na dostawę do WCSKJ produktów leczniczych stosowanych w programach lekowych i chemioterapii | –– | Wojewódzkie Centrum Szpitalne Kotliny Jeleniogórskiej | |
| Apr 14, 2026 | Zakup wraz z dostawą leków ogólnoszpitalnych dla Samodzielnego Publicznego Zakładu Opieki Zdrowotnej w Puławach, z podziałem na 83 części. | $3.4M$3,431,364 | Samodzielny Publiczny Zakład Opieki Zdrowotnej w Puławach | |
| Nov 19, 2025 | Dostawa produktów leczniczych z programów lekowych oraz nowych produktów leczniczych | $3.4M$3,393,610 | Copernicus Podmiot Leczniczy sp. z o.o. |
Public sector contracts
Astrazeneca Pharma Poland is the contractor in 59 public sector contracts, worth PLN 62.36m in total. They were signed with 22 public buyers. The largest number (2) were signed with Uniwersyteckie Centrum Kliniczne.
| Public buyer | Value | |
|---|---|---|
| Podhalański Szpital Specjalistyczny Im. Jana Pawła II w Nowym Targu | PLN 5,278 | |
| Samodzielny Publiczny Zakład Opieki Zdrowotnej Szpital Kolejowy w Wilkowicach-Bystrej /S.P.Z.O.Z. Szpital Kolejowy w Wilkowicach-Bystrej/ | PLN 9.94 | |
| Podhalański Szpital Specjalistyczny Im. Jana Pawła II w Nowym Targu | PLN 8,480 | |
| Wielospecjalistyczny Szpital Samodzielny Publiczny Zakład Opieki Zdrowotnej w Nowej Soli | PLN 43,112 | |
| Uniwersytecki Szpital Kliniczny Nr 1 Im. Prof. Tadeusza Sokołowskiego Pum w Szczecinie | PLN 15,211 |
Trademarks
Astrazeneca Pharma Poland currently holds no active trademarks with the Polish Patent Office. 2 marks have expired or were not registered. The first mark was filed in 2003.
| Mark | Protected until | |
|---|---|---|
| KLUB INTENSYWISTÓW WARSZAWSKICH | – | |
| WOLNOŚĆ ODDECHU(word) | – |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Authorized Representatives
Manner of representation
Each of the members of the management board is authorized to make declarations and sign documents on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Astrazeneca Continent B.v. | 99 | $13,371.15 | 2.475% |
Others | 3,901 | $526,877.36 | 97.525% |
Beneficial owners
| Person | Rights |
|---|---|
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Polpharma BiologicsS.A. | $311,661,837.06 | polpharmabiologics.com | ||
| SelvitaS.A. | $91,692,114.52 | selvita.com |
Change history
| Date | Event | |
|---|---|---|
| 2015-12-29 | Address change (Postępu 18, 02-676, Warszawa → Ul. Postępu 14, 02-676, Warszawa) | |
| 2007-01-02 | Address change (Domaniewska 41, 02-672, Warszawa → Postępu 18, 02-676, Warszawa) | |
| 2003-11-25 | Share capital change (50,000.00 PLN → 2,000,000.00 PLN) | |
| 2003-10-09 | Address change (Mineralna 15, 02-274, Warszawa → Domaniewska 41, 02-672, Warszawa) | |
| 2002-08-19 | Address change (Krucza 16/22, 00-526, Warszawa → Mineralna 15, 02-274, Warszawa) |
FAQ
Last updated: 2026-10-07